1. Home
  2. Pharma and Healthcare

Category: Pharma and Healthcare

Five Arrows kicks off Laf Santé sale

Five Arrows has kicked off the sale of French Laf Santé, formerly known as Lafayette Conseil, five sources familiar with the situation said.

Hg’s MEDIFOX sale launch draws large-cap sponsor interest

Hg has launched a sale for its portfolio company MEDIFOX DAN in a process that is poised to attract high sponsor interest in the German healthcare software company, according to five sources familiar with the

Goldman Sachs AM beats sponsors to buy Norgine

Goldman Sachs Asset Management will acquire Dutch pharmaceuticals company Norgine, beating out Bain and Cinven in the final leg of an auction.

CD&R, TPG team up for $4bn-Covetrus take private deal

Global buyout giant Clayton, Dubilier & Rice and TPG Capital has agreed to take animal-health technology company Covetrus private at $4bn valuation. The post CD&R, TPG team up for $4bn-Covetrus take private deal first appeared on

Cathay Capital launches €500m health fund for tech-enabled healthcare, life science investments

Cathay Capital has launched a new €500m health fund to invest in healthcare, life sciences and technology. The post Cathay Capital launches €500m health fund for tech-enabled healthcare, life science investments first appeared on AltAssets

Cathay Capital launches EUR 500m health fund

French investor Cathay Capital has launched a new EUR 500m venture and growth fund that will invest at the intersection of healthcare, life sciences and technology.

Sovereign Capital readies Nurse Plus for exit

Sovereign Capital has hired Clearwater International to explore a sale of UK-based healthcare staff agency Nurse Plus, two sources familiar with the situation said.

KKR Leads $200+ Million Growth Investment in Enterprise Identity Protection Leader Semperis

Semperis, a pioneer in identity-driven cyber resilience for enterprises, today announced it has raised over $200 million in Series C funding led by KKR, with participation from Ten Eleven Ventures, Paladin Capital Group, Atrium Health

Second director-level hire in weeks for Lead Capital Partners sees Carl Grote join team

Healthcare-focused buyout house Lead Capital Partners has made its second director-level hire in just a few weeks by bringing in Carl Grote. Grote previously worked in the investment banking departments of Janney Montgomery Scott and Robert

Montagu launches Arkopharma sale; attracts PE and trade buyers

Sponsor Montagu has launched the Rothschild-led sale of its French natural medicines and food supplements maker Arkopharma, with IMs distributed in the past week, four sources familiar with the matter said.

CVC to buy sports nutrition specialist The Quality Group

CVC Capital has agreed to acquire a majority stake in The Quality Group, a German manufacturer of sports performance nutrition products and healthy and low-sugar food alternatives.

HealthQuest outstrips Funds II and III combined with $675m hard cap Fund IV close

Sector specialist investor HealthQuest Capital has hit a $675m hard cap final close for its fourth flagship fundraise. The post HealthQuest outstrips Funds II and III combined with $675m hard cap Fund IV close first

BC Partners, Cinven, Apax and Wendel circle Havea sale

A host of sponsors, strategic players and a family office are circling French natural consumer healthcare manufacturer Havea ahead of non-binding bids next month, according to six sources familiar with the situation.

Ex-Golden Gate tech expert Chandna said to eye at least $500m for debut Lone View fundraise

Long-time Golden Gate Capital tech investor Rishi Chandna has reportedly left the firm to launch his own buyout fund, which could look to raise between $500m and $1bn. The post Ex-Golden Gate tech expert Chandna

Ampersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder

Malvern, PA, Cambridge, UK, and Sandwich, UK, May 17, 2022 – Alliance Pharma, a US-based Bioanalytical CRO and an Ampersand portfolio company, has agreed to acquire DDS, a UK-based Bioanalytical Business Unit of LGC. KKR

NovaQuest strikes $500m hard cap for latest life science, pharma services-focused private equity fund

NovaQuest Capital Management has struck a $500m hard cap close for its latest private equity investment fund. The post NovaQuest strikes $500m hard cap for latest life science, pharma services-focused private equity fund first appeared

QPE backs MBO of Republic M!

London-based Queen's Park Equity has acquired Republic M! (RM!), which provides digital media services for the healthcare sector, in a management buyout.

Permira to sell healthcare technology management Althea to infrastructure investorsF2i, DWS

Global buyout major Permira has agreed to sell healthcare technology management services provider Althea Group to a consortium formed by infrastructure investors F2i and DWS. The post Permira to sell healthcare technology management Althea to

ArchiMed exits Eurolyser to trade for 6x return

Healthcare specialist private equity firm ArchiMed has sold Austrian point-of-care testing specialist Eurolyser to the veterinary diagnostics arm of Mars Incorporated for a 6x return.

Oak Hill Capital adds healthcare veteran David Pryor as senior advisor

Oak Hill Capital Partners has hired healthcare veteran David Pryor as a senior advisor. The post Oak Hill Capital adds healthcare veteran David Pryor as senior advisor first appeared on AltAssets Private Equity News.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.